2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
8
Phase 3
5
Phase 2
4
Phase 1/2
2
Status
Not yet recruiting
2
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
3
OTHER
1
Study Type
Interventional
4
Sponsor
Cancer Type
Breast
3
Tumor-Agnostic
1
Conditions
Breast Neoplasms
2
Neoplasm Metastasis
1
Advanced Breast Cancer
1
Interventions
Cisplatin
1514
Carboplatin
1416
Cyclophosphamide
1359
Gemcitabine
1235
Bevacizumab
1223
Paclitaxel
1210
Radiotherapy
1173
Docetaxel
1079
pembrolizumab
1026
Oxaliplatin
934
Capecitabine
898
Fluorouracil
832
Rituximab
729
Doxorubicin
683
Nivolumab
679
Dexamethasone
665
Etoposide
660
Irinotecan
622
Leucovorin
574
Pemetrexed
508
Drug Therapy
491
Cetuximab
481
Trastuzumab
467
Cytarabine
466
Magnetic Resonance Spectroscopy
457
Filgrastim
446
Prednisone
432
Lenalidomide
409
Specimen Handling
407
Temozolomide
400
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 2
×
AZD9833
×
Clear all
NCT07427394
2026-02-23
SERENA-1b
AstraZeneca
Phase 2
Not yet recruiting
24 enrolled
NCT04214288
2025-11-20
SERENA-2
AstraZeneca
Phase 2
Active not recruiting
240 enrolled
16 charts
NCT07195227
2025-10-02
CADILLAC
MedSIR
Phase 2
Not yet recruiting
150 enrolled
NCT04588298
2025-01-24
SERENA-3
AstraZeneca
Phase 2
Completed
135 enrolled
17 charts